14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $11.01 $14.21 Friday, 3rd May 2024 IOVA stock ended at $13.63. This is 5.82% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.36% from a day low at $13.30 to a day high of $13.88.
90 days $7.62 $18.33
52 weeks $3.21 $18.33

Historical Iovance Biotherapeutics, Inc. prices

Date Open High Low Close Volume
Jun 12, 2023 $7.86 $8.52 $7.85 $8.49 5 648 949
Jun 09, 2023 $8.00 $8.05 $7.72 $7.89 3 511 475
Jun 08, 2023 $8.25 $8.30 $7.93 $8.00 6 009 792
Jun 07, 2023 $8.20 $8.39 $8.12 $8.24 4 469 124
Jun 06, 2023 $8.15 $8.32 $8.08 $8.18 6 504 281
Jun 05, 2023 $8.80 $8.86 $8.11 $8.22 7 746 164
Jun 02, 2023 $8.86 $9.00 $8.66 $8.80 4 955 160
Jun 01, 2023 $8.75 $9.12 $8.60 $8.73 7 650 864
May 31, 2023 $8.84 $9.15 $8.62 $8.74 11 628 217
May 30, 2023 $9.20 $9.20 $8.15 $8.85 20 261 578
May 26, 2023 $7.53 $7.70 $7.32 $7.55 5 252 299
May 25, 2023 $8.07 $8.18 $7.12 $7.69 9 913 614
May 24, 2023 $9.10 $9.10 $8.04 $8.07 8 641 017
May 23, 2023 $8.22 $9.36 $8.21 $9.06 13 570 374
May 22, 2023 $7.44 $8.29 $7.42 $7.99 5 472 424
May 19, 2023 $7.52 $7.68 $7.28 $7.36 2 998 931
May 18, 2023 $7.53 $7.53 $7.20 $7.44 3 289 036
May 17, 2023 $7.62 $7.65 $7.08 $7.50 4 264 641
May 16, 2023 $7.73 $7.73 $7.44 $7.49 4 853 716
May 15, 2023 $7.50 $8.00 $7.45 $7.84 5 232 875
May 12, 2023 $7.57 $7.64 $7.29 $7.47 2 899 078
May 11, 2023 $7.62 $7.84 $7.44 $7.50 3 730 698
May 10, 2023 $7.62 $7.97 $7.42 $7.64 7 265 288
May 09, 2023 $7.06 $7.41 $7.03 $7.36 4 567 953
May 08, 2023 $6.90 $7.24 $6.71 $7.08 4 604 049
Click to get the best stock tips daily for free!

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics. Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers... IOVA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT